Mexico Radiation Oncology Market Size & Outlook, 2020-2028

The radiation oncology market in Mexico is expected to reach a projected revenue of US$ 140.0 million by 2028. A compound annual growth rate of 8.4% is expected of Mexico radiation oncology market from 2021 to 2028.
Revenue, 2020 (US$M)
$73.4
Forecast, 2028 (US$M)
$140.0
CAGR, 2021 - 2028
8.4%
Report Coverage
Mexico

Mexico radiation oncology market highlights

  • The Mexico radiation oncology market generated a revenue of USD 73.4 million in 2020 and is expected to reach USD 140.0 million by 2028.
  • The Mexico market is expected to grow at a CAGR of 8.4% from 2021 to 2028.
  • In terms of segment, external beam radiationtherapy was the largest revenue generating type in 2020.
  • Internal Beam Radiation Therapy is the most lucrative type segment registering the fastest growth during the forecast period.


Radiation oncology market data book summary

Market revenue in 2020USD 73.4 million
Market revenue in 2028USD 140.0 million
Growth rate8.4% (CAGR from 2020 to 2028)
Largest segmentExternal beam radiationtherapy
Fastest growing segmentInternal Beam Radiation Therapy
Historical data2017 - 2019
Base year2020
Forecast period2021 - 2028
Quantitative unitsRevenue in USD million
Market segmentationExternal Beam RadiationTherapy, Internal Beam Radiation Therapy
Key market players worldwideSiemens Healthineers AG ADR, Elekta AB ADR, BD, Accuray Inc, IBA RadioPharma Solutions, IsoRay, MeVis Medical Solutions AG, Nordion, Ntp Radioisotopes, Curium Pharma, ViewRay


Other key industry trends

  • In terms of revenue, Mexico accounted for 1.0% of the global radiation oncology market in 2020.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
  • In Latin America, Brazil radiation oncology market is projected to lead the regional market in terms of revenue in 2028.
  • Mexico is the fastest growing regional market in Latin America and is projected to reach USD 140.0 million by 2028.

External beam radiationtherapy was the largest segment with a revenue share of 71.39% in 2020. Horizon Databook has segmented the Mexico radiation oncology market based on external beam radiationtherapy, internal beam radiation therapy covering the revenue growth of each sub-segment from 2017 to 2028.


Radiation oncology market in Mexico is expected to grow at a significant pace owing to increase in the number of strategic initiatives being undertaken by key market players. In April 2018, Elekta AB received the government approval for the supply of MOSAIQ oncology information system.

Monaco treatment planning software, and five linear accelerators including Elekta Synergy and Elekta Infinity systems to Instituto Mexicano del Seguro Social (IMSS), Mexico. In addition, rising incidence of cancer is expected to boost the demand for radiotherapy in the market. 

According to WHO, in Mexico, around 27,283 new cases of breast cancer were reported in 2018 while 6,884 people died due to this disease. Moreover, 25,049 new cases of prostate cancer were reported and 6,915 deaths occurred due to the disease. Prostate cancer is the most common cause of deaths in the country.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Radiation Oncology Market Companies

Name Profile # Employees HQ Website

Mexico radiation oncology market size, by type, 2017-2028 (US$M)

Mexico Radiation Oncology Market Outlook Share, 2020 & 2028 (US$M)

Mexico radiation oncology market size, by type, 2017-2028 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more